Moreover, STAT3 signaling was inhibited when various tumor cell lines were received treatment of mTOR inhibitor rapamycin [66], which supports our observation that STAT3 phosphorylation was inhibited by the combination of PQR309 and gemcitabine. The gene discussed is STAT3; the disease is neoplasm.